13D Filing: Aisling Capital III LP and Transenterix Inc. (TRXC)

Page 2 of 12

Page 2 of 12 – SEC Filing

CUSIP No. 89366M102
SCHEDULE 13D/A
Page 2 of 12
1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Aisling Capital III, LP
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)  o
(b)  x
3
SEC USE ONLY
4
SOURCE OF FUNDS
OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
10,335,819
8
SHARED VOTING POWER
-0-
9
SOLE DISPOSITIVE POWER
10,335,819
10
SHARED DISPOSITIVE POWER
-0-
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
10,335,819
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.0% (1)
14
TYPE OF REPORTING PERSON
PN

(1)
All calculations of the percentages herein are based on an aggregate of 148,529,689 shares of Common Stock issued and outstanding as of May 3, 2017 (excluding any options, warrants, or other rights to acquire the Issuers Common Stock), as reported in the Issuers Form 424(b)(5) Prospectus Supplement filed with the Securities Exchange Commission (the SEC) on May 1, 2017.

Follow Asensus Surgical Inc. (NYSEMKT:ASXC)

Page 2 of 12